Yuta Hiraike

Yuta Hiraike

Auto-generated profile, based on publicly available information

Yuta Hiraike

Division for Health Service Promotion, The University of Tokyo , 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
YAYusuke Adachi
Yusuke Adachi
KUKazutaka Ueda
Kazutaka Ueda
SNSeitaro Nomura
Seitaro Nomura
KIKaoru Ito
Kaoru Ito
MKManami Katoh
Manami Katoh
IKIssei Komuro
Issei Komuro
Although inflammation plays critical roles in the development of atherosclerosis, its regulatory mechanisms remain incompletely understood. Perivascular adipose tissue (PVAT) has been reported to undergo inflammatory changes in response to vascular injury. Here, we show that vascular injury induces the beiging (brown adipose tissue-like phenotype change) of PVAT, which fine-tunes inflammatory response and thus vascular remodeling as a protective mechanism. In a mouse model of endovascular injury, macrophages accumulate in PVAT, causing beiging phenotype change. Inhibition of PVAT beiging by genetically silencing PRDM16, a key regulator to beiging, exacerbates inflammation and vascular remodeling following injury. Conversely, activation of PVAT beiging attenuates inflammation and pathological vascular remodeling. Single-cell RNA sequencing reveals that beige adipocytes abundantly express neuregulin 4 (Nrg4) which critically regulate alternative macrophage activation. Importantly, significant beiging is observed in the diseased aortic PVAT in patients with acute aortic dissection. Taken together, vascular injury induces the beiging of adjacent PVAT with macrophage accumulation, where NRG4 secreted from the beige PVAT facilitates alternative activation of macrophages, leading to the resolution of vascular inflammation. Our study demonstrates the pivotal roles of PVAT in vascular inflammation and remodeling and will open a new avenue for treating atherosclerosis.

24 July 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YHYuta Hiraike
Yuta Hiraike
KSKaede Saito
Kaede Saito
MOMisato Oguchi
Misato Oguchi
TWTakahito Wada
Takahito Wada
GTGotaro Toda
Gotaro Toda
TYToshimasa Yamauchi
Toshimasa Yamauchi
Adipose tissue is central to regulation of energy homeostasis. Adaptive thermogenesis, which relies on mitochondrial oxidative phosphorylation (Ox-Phos), dissipates energy to counteract obesity. On the other hand, chronic inflammation in adipose tissue is linked to type 2 diabetes and obesity. Here, we show that nuclear factor I-A (NFIA), a transcriptional regulator of brown and beige adipocytes, improves glucose homeostasis by upregulation of Ox-Phos and reciprocal downregulation of inflammation. Mice with transgenic expression of NFIA in adipocytes exhibited improved glucose tolerance and limited weight gain. NFIA up-regulates Ox-Phos and brown-fat-specific genes by enhancer activation that involves facilitated genomic binding of PPARγ. In contrast, NFIA in adipocytes, but not in macrophages, down-regulates proinflammatory cytokine genes to ameliorate adipose tissue inflammation. NFIA binds to regulatory region of the Ccl2 gene, which encodes proinflammatory cytokine MCP-1 (monocyte chemoattractant protein-1), to down-regulate its transcription. CCL2 expression was negatively correlated with NFIA expression in human adipose tissue. These results reveal the beneficial effect of NFIA on glucose and body weight homeostasis and also highlight previously unappreciated role of NFIA in suppressing adipose tissue inflammation.

30 December 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
TYTomohide Yamada
Tomohide Yamada
Daisuke YoneokaDaisuke Yoneoka
Daisuke Yoneoka
YHYuta Hiraike
Yuta Hiraike
KHKimihiro Hino
Kimihiro Hino
HTHiroyoshi Toyoshiba
Hiroyoshi Toyoshiba
TYToshimasa Yamauchi
Toshimasa Yamauchi
Background: Performing systematic reviews is a time-consuming and resource-intensive process. Objective: We investigated whether a machine learning system could perform systematic reviews more efficiently. Methods: All systematic reviews and meta-analyses of interventional randomized controlled trials cited in recent clinical guidelines from the American Diabetes Association, American College of Cardiology, American Heart Association (2 guidelines), and American Stroke Association were assessed. After reproducing the primary screening data set according to the published search strategy of each, we extracted correct articles (those actually reviewed) and incorrect articles (those not reviewed) from the data set. These 2 sets of articles were used to train a neural network–based artificial intelligence engine (Concept Encoder, Fronteo Inc). The primary endpoint was work saved over sampling at 95% recall (WSS@95%). Results: Among 145 candidate reviews of randomized controlled trials, 8 reviews fulfilled the inclusion criteria. For these 8 reviews, the machine learning system significantly reduced the literature screening workload by at least 6-fold versus that of manual screening based on WSS@95%. When machine learning was initiated using 2 correct articles that were randomly selected by a researcher, a 10-fold reduction in workload was achieved versus that of manual screening based on the WSS@95% value, with high sensitivity for eligible studies. The area under the receiver operating characteristic curve increased dramatically every time the algorithm learned a correct article. Conclusions: Concept Encoder achieved a 10-fold reduction of the screening workload for systematic review after learning from 2 randomly selected studies on the target topic. However, few meta-analyses of randomized controlled trials were included. Concept Encoder could facilitate the acquisition of evidence for clinical guidelines.

30 April 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
YHYuta Hiraike
Yuta Hiraike
CYChao-Tung Yang
Chao-Tung Yang
WLWei-Ju Liu
Wei-Ju Liu
TYTomohide Yamada
Tomohide Yamada
CLChia Lin Lee
Chia Lin Lee
Context Gene–exercise interaction on cross-sectional body mass index (BMI) has been extensively studied and is well established. However, gene–exercise interaction on changes in body weight/BMI remains controversial. Objective To examine the interaction between the FTO obesity variant and regular exercise on changes in body weight/BMI. Participants Taiwan Biobank participants aged 30-70 years (N = 20 906) were examined at both baseline and follow-up visit (mean follow-up duration: 3.7 years). Main Outcome Measures The interaction between the FTO obesity variant rs1421085 and regular exercise habit (no exercise, ≤20 metabolic equivalent of tasks (METs)/week exercise, >20 METs/week exercise) on changes in body weight/BMI. Results Individuals with the risk allele of rs1421085 gained more weight and increased BMI than those without the risk allele if they did not exercise. In contrast, individuals with the risk allele gained less weight and BMI if they exercised regularly, indicating an interaction between rs1421085 and regular exercise habit (P = .030 for Δbody weight and P = .034 for ΔBMI). The effect of exercise on maintaining body weight was larger in those with the risk allele of rs1421085. When we focused on individuals without regular exercise at baseline, individuals with the risk allele again tended to lose more weight than those with a nonrisk allele if they had acquired an exercise habit by the follow-up visit. Conclusion The beneficial effect of exercise is greater in individuals genetically prone to obesity due to the interaction between the FTO obesity variant rs1421085 and regular exercise on changes in body weight and BMI.

1 January 2013 in World Journal of Gastroenterology
Verified
Journal Article
Open access
YHYuta Hiraike
Yuta Hiraike
MKMakoto Kodaira
Makoto Kodaira
MSMunetaka Sano
Munetaka Sano
YTYasuyuki Terazawa
Yasuyuki Terazawa
SYShingo Yamagata
Shingo Yamagata
KKKen Kuriki
Ken Kuriki
The differential diagnosis of acute abdomen is typically extremely broad in range, with vasculitis posing a rare but potentially life-threatening cause of acute abdomen. Here, we report a case of acute abdomen with bowel wall thickening limited to jejunum, accompanied by unexplained renal dysfunction. Later, the patient was diagnosed as having polyarteritis nodosa based on surgically resected jejunal necrosis. Despite aggressive treatment, including the use of steroid pulse therapy and continuous hemodiafiltration, the patient died. Although polyarteritis nodosa is extremely rare in patients with acute abdomen, acute abdomen is relatively common manifestation of that. And it is reported that involvement of small intestine suggests poorer prognosis. Our case highlights the importance of vasculitis as a differential diagnosis of patients with atypical acute abdomen. In this report, we not only review possible clues that might have led to an earlier diagnosis in this case, but also attempt to draw some lessons for treating similar cases in the future.

22 February 2024 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
PDF file
CLChia Lin Lee
Chia Lin Lee
TYTomohide Yamada
Tomohide Yamada
WLWei-Ju Liu
Wei-Ju Liu
KHKazuo Hara
Kazuo Hara
SYShintaro Yanagimoto
Shintaro Yanagimoto
YHYuta Hiraike
Yuta Hiraike
Aims: The beneficial effects of exercise on reducing the risk of cardiovascular disease are established. However, the potential interaction between genetic risk for type 2 diabetes and physical activity on cardiovascular outcomes remains elusive. We aimed to investigate the effect of type 2 diabetes genetic risk–physical activity interaction on cardiovascular outcomes in individuals with diabetes. Methods and results: Using the UK Biobank cohort, we investigated the effect of type 2 diabetes genetic risk–physical activity interaction on three-point and four-point major adverse cardiovascular events (MACE), in 25 701 diabetic participants. We used a polygenic risk score for type 2 diabetes (PRS_T2D) as a measure of genetic risk for type 2 diabetes. We observed a significant interaction between PRS_T2D and physical activity on cardiovascular outcomes (three-point MACE: P trend for interaction = 0.0081; four-point MACE: P trend for interaction = 0.0037). Among participants whose PRS_T2D was in the first or second quartile, but not in the third or fourth quartile, each 10 metabolic equivalents (METs) hours per week of physical activity decreased the risk of three-point or four-point MACE. Furthermore, restricted cubic spline analysis indicated that intense physical activity (>80 METs hours per week, which was self-reported by 12.7% of participants) increased the risk of cardiovascular outcomes among participants whose PRS_T2D was in the fourth quartile. Sub-group analysis suggested that negative impact of intense physical activity was observed only in non-insulin users. Conclusion: The beneficial effect of physical activity on cardiovascular outcomes disappeared among those with high genetic risk for type 2 diabetes.